New Company Developing Immune Therapeutics for Autoimmunity and Cancer

24 May 2023

​

A new Australian biotech company, Resseptor Therapeutics (‘Resseptor’), has launched with an initial AU$2.25 million investment to develop new therapies targeting autoimmune diseases and cancer.